Poster Poster Program Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Post-Treatment Dosimetry Following Yttrium-90 Radioembolization: A Clinical Comparison of Nuclear Medicine and CT-Based Approaches

Abstract
Purpose

Present interim dosimetry analysis from a prospective, multi-center study (NCT05953337) comparing the mean absorbed dose (Dmean) derived from nuclear medicine (NM) and CT imaging of liver cancer patients undergoing yttrium-90-radioembolization (90Y-RE) with radiopaque Eye90 microspheres.

Methods

Twenty-seven patients were treated with Eye90 microspheres. Post-treatment, patients were imaged with CT and NM (SPECT [n=9], PET [n=18]) to measure the absorbed dose to the perfused volume (PV) and tumor (T). In NM-based dosimetry, Dmean was calculated using voxel S-values for PET and the local deposition method for SPECT. For CT, Dmean was calculated through calibration phantom analysis and convolution with a dose-voxel kernel. Dmean was compared using linear regression and Bland-Altman analysis. Correlation coefficients, percent difference ± standard error (bias), and 95% limits of agreement (precision) between Dmean are reported. For PV, Dmean was also compared to a ground truth, single compartment MIRD-based Dmean.

Results

When comparing Dmean from CT- and NM-based dosimetry to MIRD-based Dmean, CT demonstrates significantly improved agreement. There is a very strong correlation between CT- and MIRD-based Dmean to PV (R2=0.96). In NM, the correlation was far weaker (R2=0.56). The MIRD-based Dmean was generally greater than both CT- or NM-based Dmean, particularly NM. For CT, bias and precision were 44±13% and 64%, respectively. For NM, bias and precision were 70±16% and 78%. When comparing Dmean between CT and NM, there was a moderate correlation between for PV (R2=0.57) and a weak correlation for T (R2=0.36). Dmean was generally greater in CT-based dosimetry relative to NM. For PV, bias and precision were 31±19% and 94%, respectively. For T, bias and precision were 10±21% and 104%.

Conclusion

For PV, CT-based dosimetry revealed that Dmean maintained a significantly stronger correlation with the MIRD-based Dmean, relative to NM. CT-based dosimetry had a reduced bias and improved precision relative to NM-based dosimetry.

People

Related

Similar sessions

Poster Poster Program
Jul 19 · 07:00
Adverse Events in Targeted Radionuclide Therapy

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

Harrison L. Agordzo
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Development of a Web-Based Theranostic Workflow Management Tool

To develop a Web-Based Theranostic Workflow Management Tool (TWMT) to efficiently manage Theranostic program in the department of radiation oncology (RadOnc).

Ling Zhuang, PhD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Epidseg-Net:the Multi-Modal Fusion Framework Based on Drr Guidance In Radiotherapy Is Used for Precise Segmentation of Epid Lung Targets

The proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture featu...

Huang Qian Qianjia, M.Eng
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested